Recent Comments

Comment RSS

Atrial Fibrillation News and Research RSS Feed - Atrial Fibrillation News and Research

Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.

Biotel reports net earnings of $128,000 for its first quarter ended September 30, 2009

20. November 2009 10:43
Biotel Inc. announced results for its first quarter ended September 30, 2009 with net earnings of $128,000, or $0.04 per diluted share, on revenues of $3,263,000. This compares to net earnings of $328,000, or $0.11 per diluted share, on revenues of $3,168,000 for the first quarter of last year. [More]

Posted in: Business / Finance

Tags: , ,

Positive short term results from combined surgical and electrophysiological approach to treat AF

20. November 2009 03:59
nContact Surgical, Inc., a leader in the investigation of devices for minimally-invasive treatment for heart conditions, announced that data from a poster was presented at the American Heart Association Scientific Sessions in Orlando. The study demonstrated that the convergent approach, which combines surgical and electrophysiological expertise, appears to be a good strategy to achieve short term success in patients with long standing persistent atrial fibrillation (AF). [More]

Posted in: Device / Technology News | Medical Condition News

Tags: ,

Joint project focuses on finding ways to prevent dementia, including Alzheimer's disease

19. November 2009 02:36
Every two years, 2,000 senior Group Health patients check in with the Adult Changes in Thought (ACT) study. The joint project between Group Health Research Institute and the University of Washington (UW) focuses on finding ways to delay or prevent dementia, including Alzheimer's disease, and declines in memory and thinking. [More]

St. Jude Medical announces implantation of the first patient in China with its Eon rechargeable neurostimulator

18. November 2009 10:54
St. Jude Medical, Inc. announced today that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: , , , , ,

New report on the European cardiac rhythm management, electrophysiology, and ablation devices market

18. November 2009 05:38
In 2008, the market for cardiac rhythm management, electrophysiology, and ablation devices was valued at nearly euro 2.2 billion ($3.4 billion), an 11.2% increase over 2007. [More]

Posted in: Device / Technology News

Tags: ,

Review of the results of Phase 2b clinical trial on PASCAL announced

18. November 2009 02:41
ARYx Therapeutics, Inc., a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx’s compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida. [More]

Posted in: Drug Trial News | Medical Condition News

Tags: , ,

Report on the U.S. cardiac surgery devices market

18. November 2009 01:46
In 2008, the U.S. market for cardiac surgery devices was valued at over $1.6 billion, representing growth of nearly 7% over 2007. [More]

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

17. November 2009 04:03
deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it has filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code with the United States Bankruptcy Court for the District of Delaware to facilitate the sale of substantially all of its assets. deCODE is continuing to operate its business and manage its properties as a debtor-in-possession pursuant to Sections 1107 and 1108 of the Bankruptcy Code. [More]

Genetic test for familial Dilated Cardiomyopathy launched by PGxHealth

16. November 2009 08:54
PGxHealth, a division of Clinical Data, Inc., today announced the launch of its genetic test for familial Dilated Cardiomyopathy, an inherited heart disease which is the leading cause of heart transplants and a possible cause of sudden cardiac death. [More]

RecordAF presents results of recently diagnosed and treated patients with atrial fibrillation

16. November 2009 06:07
Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific Sessions of the American Heart Association, show that in recently diagnosed and actively treated patients with atrial fibrillation (AF), a rhythm-control strategy provides better short term control of the arrhythmia versus a rate-control strategy but does not translate into a reduction in the occurrence of clinical events at 1 year. [More]

Posted in: Medical Condition News

Tags: , , , ,

Merck to market and develop cardiovascular medicines for a range of cardiovascular disorders

16. November 2009 02:20
Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders. [More]

ARYx Therapeutics announces operating results for the third quarter of 2009

12. November 2009 11:10
ARYx Therapeutics, Inc. today reported results of operations and provided a general business update for the third quarter ended September 30, 2009. [More]

Posted in: Business / Finance

Tags: , , ,

New mapping technology to treat patients with heart rhythm disorders

11. November 2009 01:30
Physicians with California Pacific Medical Center are among the first in the nation to use a new advanced mapping technology to help treat patients suffering from debilitating and potentially dangerous heart rhythm disorders. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: , , , , ,

IntriCon to launch new CDM device at 2009 AHA Scientific Sessions

11. November 2009 00:41
IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, announced today that it will unveil a prototype of its new Cardiac Diagnostic Monitoring (CDM) device, called the Mobile Patient ECG Telemetry System, or MPETS, at the 2009 American Heart Association (AHA) Scientific Sessions, Nov. 15-17, in Orlando, Fla. [More]

Posted in: Device / Technology News

Tags: ,

Cardiome Pharma announces financial results for the three months ended September 30, 2009

9. November 2009 09:09
Cardiome Pharma Corp. today reported financial results for the third quarter ended September 30, 2009. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP). [More]

Posted in: Business / Finance

Tags: , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.